Shenzhen Chipscreen Biosciences Co Buchwert je Aktie
Was ist das Buchwert je Aktie von Shenzhen Chipscreen Biosciences Co?
Buchwert je Aktie von Shenzhen Chipscreen Biosciences Co., Ltd. ist 2.99
Was ist die Definition von Buchwert je Aktie?
Der Buchwert pro Aktie ist das Vermögen eines Unternehmens abzüglich der Verbindlichkeiten geteilt durch die Anzahl der ausstehenden Aktien.
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Buchwert je Aktie von Unternehmen in Health Care Sektor auf SSE im Vergleich zu Shenzhen Chipscreen Biosciences Co
Was macht Shenzhen Chipscreen Biosciences Co?
Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.
Unternehmen mit buchwert je aktie ähnlich Shenzhen Chipscreen Biosciences Co
- Enochian Biosciences hat Buchwert je Aktie von 2.98
- China High Speed Transmission Equipment Co hat Buchwert je Aktie von 2.98
- Avacta Plc hat Buchwert je Aktie von 2.98
- Minoan Plc hat Buchwert je Aktie von 2.98
- People hat Buchwert je Aktie von 2.98
- William Hill Plc hat Buchwert je Aktie von 2.99
- Shenzhen Chipscreen Biosciences Co hat Buchwert je Aktie von 2.99
- Heng Tai Consumables hat Buchwert je Aktie von 2.99
- Tubacex, S.A hat Buchwert je Aktie von 2.99
- Ronshine China hat Buchwert je Aktie von 2.99
- American Software hat Buchwert je Aktie von 2.99
- Origin Enterprises plc hat Buchwert je Aktie von 2.99
- FIH Mobile hat Buchwert je Aktie von 3.00